A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• The Wilms' tumor suppressor gene (WT1) encodes a transcription factor crucial for regulating cell growth.
• WT1 protein isoforms arise from alternative splicing, including an insertion in exon 5 that enhances transcriptional repression.

Purpose of the Study:

• To investigate the functional impact of a specific WT1 mutation found in a Wilms' tumor patient.
• To determine how this mutation affects WT1's transcriptional repression and growth-inhibiting activities.

Main Methods:

• Identification of a point mutation in exon 5 of the WT1 gene in a Wilms' tumor patient.
• Transient cotransfection assays to assess the transcriptional repressing activity of the mutated WT1.
• Evaluation of the mutated WT1's growth-inhibiting effects in osteosarcoma cell lines (U2OS and Saos-2).

Main Results:

• A mutation changing asparagine to serine in exon 5 of WT1 was identified.
• The mutated WT1 exhibited a 2-3 fold reduction in transcription-repressing activity compared to wild-type.
• The mutation also decreased the growth-inhibiting capacity of WT1 in U2OS and Saos-2 cells.

Conclusions:

• The identified mutation in WT1's exon 5 diminishes its tumor-suppressive functions.
• Reduced transcriptional repression and growth inhibition by WT1 may contribute to the pathogenesis of Wilms' tumor.
• This study highlights the importance of WT1's exon 5 domain in preventing uncontrolled cell proliferation.